Spyre Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
221 Crescent St Ste 105, Waltham, Massac...Phone Number
(617) 651-5940Website
www.spyre.comRevenue
-Stock Symbol
SYREIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Spyre Therapeutics
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.Explore more
Spyre Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Spyre Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Spyre Therapeutics is spiking on competitors!
Spyre Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Spyre Therapeutics had a recent Job posting/layoffs
Product Launch: Get notified when Spyre Therapeutics launches new products
Funding: Get notified immidiatlly once Spyre Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Spyre Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Spyre Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Spyre Therapeutics
Recommended Actions
Reach out to Masked Content who joined Spyre Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Spyre Therapeutics
Compare insights from companies similar to Spyre Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Spyre Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Spyre Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Spyre Therapeutics.
Spyre Therapeutics Tech Stack
A closer look at the technologies used by Spyre Therapeutics
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Clinical Operations
Earnings
Earnings, Finance
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
Spyre Therapeutics News & Media
Spyre Therapeutics, Inc. (SYRE) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Spyre Therapeutics, Inc. (SYRE) Goldman Sachs 47th Annual Global Healthcare Conference 2026 June 8, 2026 10:00 AM EDTCompany ParticipantsCameron Turtle -...Spyre Therapeutics Announces Grants of Inducement Awards
WALTHAM, Mass., June 05, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that Spyre’s independent Compensation Committee of the Board of Directors approved the grant of stock options to purchase aSpyre Therapeutics (SYRE): 12 Best High Short Interest Stocks With Highest Upside Potential
Spyre Therapeutics Inc. (NASDAQ:SYRE) is one of the best high short interest stocks with highest upside potential. On May 5, Spyre Therapeutics reported a strong Q1 2026, supported by a public offering that resulted in $1.2 billion in pro forma cash, providing a financial runway into late 2029. While R&D expenses rose to $60.4 million […]Spyre Therapeutics Announces Completion of Enrollment in SKYWAY Basket Trial Evaluating SPY072 (anti-TL1A) in RA, PsA, and axSpA
Enrollment for psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) sub-studies of the SKYWAY basket trial are complete
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Spyre Therapeutics
Sign Up For FreeTo access detailed company insights
Spyre Therapeutics combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for inflammatory bowel disease.... Read More
